RxDoctor Payments Data

Stephen Proctor, MD

Obstetrics & Gynecology · Oxon Hill, MDNPI 1811903792

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $111 and has fallen 61.6% since, to $43 in 2025. That places this record below the midpoint for obstetrics & gynecology clinicians in MD, where the typical reported total is $508.

$369in general payments, 2019–2025

Across 21 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$64
  • AbbVie$50
  • Scynexis, Inc.$44
  • Avion Pharmaceuticals$37
  • Therapeuticsmd, Inc.$30
  • Exact Sciences$21
  • plus $122 from 7 others

What the payments were for

  • Food & beverage$369100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$369 in reported general payments places this provider in the 40th percentile of 842 obstetrics & gynecology providers in Maryland.

See all obstetrics & gynecology providers in Maryland →

Medicare billing

Part B allowed, 2024
$18,118
Medicare patients
99
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol27$974
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$170

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Oxon Hill

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →